Versant Vantage I GP-GP, LLC

10% OwnerLAVA Therapeutics NV (LVTX) · full profile →Form 4 · filed Sep 18, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.5M
Net Open-Market Flow
-$2.5M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 18, 2025Sell(S)366K$1.44$527K2.4M
Sep 18, 2025Sell(S)229K$1.44$329K533K
Sep 17, 2025Sell(S)363K$1.49$541K2.7M
Sep 17, 2025Sell(S)227K$1.49$338K762K
Sep 16, 2025Sell(S)308K$1.53$471K3.1M
Sep 16, 2025Sell(S)192K$1.53$294K988K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-207677) within minutes of acceptance. Every field above traces to the original document. Verify it directly: